Can CT scans guide better breathing support for ARDS patients?
NCT ID NCT02149589
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether using lung CT images to guide ventilator settings could reduce deaths in people with ARDS. 420 adults were assigned to either standard ventilator care or a strategy based on their lung morphology. The goal was to see if personalized ventilation could improve survival at 90 days.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- mechanical ventilation
- What this could lead to
- If this approach works, it could lead to a more personalized way to set ventilators for ARDS patients, potentially lowering death rates.
- What could go wrong
- This is a completed trial, but the results may not show a clear benefit. The strategy is complex and may not be easy to apply in all hospitals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
420 people
The number who actually took part.
- Started
-
Jun 2014
- Finished
-
Feb 2018
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Man or female older than 18 years * ARDS since less than 12 hours * PaO2 / FiO2 \< 200 avec une PEEP ≥ 5 (Berlin Moderate or severe) Exclusion Criteria: * brain injury with high ICP * BMT Liver Cirrhosis Child C Pregnancy Burns Morbid obese patients (BMI \> 40) Moribund
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARDS are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Clermont-Ferrand
Clermont-Ferrand, 63003, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Is thicker blood a hidden player in ARDS?
- Can a wrist sensor cut the dose of ICU muscle relaxants?
- Stem cell infusion may help severely ill COVID-19 patients breathe
- Breathing new life: tailored ventilation for ARDS patients
- Blood test may spot lung risk in brain injury patients
- Can a smartphone app heal the hidden wounds of the ICU?